[ET Net News Agency, 6 February 2026] INNOCARE (09969) rose 10.2% to HK$13.05.
It hits an intra-day high of HK$13.06, breaking above the 50-D SMA of HK$13.013, and an
intra-day low of HK$11.7. The total shares traded was 11.09 million, with a value of
HK$138.74m. The active buy/sell ratio is 75:25, with net buying turnover of HK$65.39m. BNP
PARIBAS SEC (ASIA) accounts for greatest net responsive buying turnover of HK$966,996,
with volume weighted average price of HK$12.278. CHINA INV INFO accounts for greatest net
responsive selling turnover of HK$10.68m, with volume weighted average price of HK$12.539.
The stock has risen a combined 15.9% over the past 3 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 13.050 % Chg +10.22%
High 13.060 Low 11.700
Shares Tr 11.09m Turnover 138.74m
10-D SMA 11.738 %H.V 31.150
20-D SMA 12.166 VWAP 12.510
50-D SMA 13.013 RSI14 60.132
----------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 75:25, with net buying
turnover of HK$65.39m, rising a combined 15.9% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
INNOCARE (09969) 13.05 +10.22
GENSCRIPT BIO (01548) 12.01 -3.69
INNOVENT BIO (01801) 79.75 -0.19
XTALPI (02228) 11.41 +1.15
WUXI BIO (02269) 37.50 -0.05
WUXI APPTEC (02359) 114.10 +0.71
BEONE MEDICINES (06160) 205.40 -2.00
DUALITYBIO-B (09606) 313.60 -1.51
AKESO (09926) 101.30 Unchanged
REMEGEN (09995) 79.50 -1.79
-----------------------------------------------
(ed)